Cargando…

Circulating MicroRNAs as Potential Predictors of Anthracycline-Induced Troponin Elevation in Breast Cancer Patients: Diverging Effects of Doxorubicin and Epirubicin

Anthracyclines are anti-neoplastic drugs presenting cardiotoxicity as a side effect. Cardiac troponins (cTn) and echocardiography are currently used to assess cardiac damage and dysfunction, but early biomarkers identifying patients in need of preventive treatments remain a partially met need. Circu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gioffré, Sonia, Chiesa, Mattia, Cardinale, Daniela Maria, Ricci, Veronica, Vavassori, Chiara, Cipolla, Carlo Maria, Masson, Serge, Sandri, Maria Teresa, Salvatici, Michela, Ciceri, Fabio, Latini, Roberto, Staszewsky, Lidia Irene, Pompilio, Giulio, Colombo, Gualtiero I., D’Alessandra, Yuri
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7290665/ https://www.ncbi.nlm.nih.gov/pubmed/32403263 http://dx.doi.org/10.3390/jcm9051418

Ejemplares similares

Role of microRNAs in doxorubicin-induced cardiotoxicity: an overview of preclinical models and cancer patients
por: Ruggeri, Clarissa, et al.
Publicado: (2017)

A Specific Circulating MicroRNA Cluster Is Associated to Late Differential Cardiac Response to Doxorubicin-Induced Cardiotoxicity In Vivo
por: Ruggeri, Clarissa, et al.
Publicado: (2018)

Cardiotoxicity of Anthracyclines
por: Cardinale, Daniela, et al.
Publicado: (2020)

Circulating biomarkers and cardiac function over 3 years after chemotherapy with anthracyclines: the ICOS‐ONE trial
por: Meessen, Jennifer M.T.A., et al.
Publicado: (2020)

Diabetes Induces a Transcriptional Signature in Bone Marrow–Derived CD34(+) Hematopoietic Stem Cells Predictive of Their Progeny Dysfunction
por: D’Alessandra, Yuri, et al.
Publicado: (2021)

Long QT syndrome and torsade de pointes after anthracycline chemotherapy
por: Colombo, N, et al.
Publicado: (2009)

microRNAs and Cardiac Cell Fate
por: Piubelli, Chiara, et al.
Publicado: (2014)

Differential Role of Circulating microRNAs to Track Progression and Pre-Symptomatic Stage of Chronic Heart Failure: A Pilot Study
por: D’Alessandra, Yuri, et al.
Publicado: (2020)

Circulating 16S RNA in Biofluids: Extracellular Vesicles as Mirrors of Human Microbiome?
por: Ricci, Veronica, et al.
Publicado: (2020)

Cardiac Toxicity and Anthracyclines: Mechanism, Interventions, and the Trouble With Troponin
por: Thompson, Grace E., et al.
Publicado: (2019)

Human Cardiac Mesenchymal Stromal Cells From Right and Left Ventricles Display Differences in Number, Function, and Transcriptomic Profile
por: Stadiotti, Ilaria, et al.
Publicado: (2020)

Advances in anthracycline chemotherapy : epirubicin /
Publicado: (1984)

Utility of high-sensitivity cardiac troponin T in patients receiving anthracycline chemotherapy
por: Blaes, Anne H, et al.
Publicado: (2015)

Circulating MicroRNAs as Novel Biomarkers in Risk Assessment and Prognosis of Coronary Artery Disease
por: Vavassori, Chiara, et al.
Publicado: (2022)

Trained Immunity in Perivascular Adipose Tissue of Abdominal Aortic Aneurysm—A Novel Concept for a Still Elusive Disease
por: Piacentini, Luca, et al.
Publicado: (2022)

Gliadin Nanoparticles Containing Doxorubicin Hydrochloride: Characterization and Cytotoxicity
por: Voci, Silvia, et al.
Publicado: (2023)

Doxorubicin and Aclarubicin: Shuffling Anthracycline Glycans for Improved Anticancer Agents
por: Wander, Dennis P. A., et al.
Publicado: (2020)

Epirubicin
por: Cornish, J., et al.
Publicado: (1988)

Dynamic Changes in High-Sensitivity Cardiac Troponin I in Response to Anthracycline-Based Chemotherapy
por: Tzolos, E., et al.
Publicado: (2020)

The breast cancer, early disease: toxicity from therapy with epirubicin regimens - cardiac assessment and risk evaluation (BETTER-CARE) study: CMR with early gadolinium relative enhancement, but not high-sensitivity troponin T, predicts the risk of chronic anthracycline cardiotoxicity
por: Kotwinski, Paul, et al.
Publicado: (2013)

Diagnostic Potential of Plasmatic MicroRNA Signatures in Stable and Unstable Angina
por: D'Alessandra, Yuri, et al.
Publicado: (2013)

Pegylated Liposomal Doxorubicin Versus Epirubicin as Adjuvant Therapy for Stage I–III Breast Cancer
por: Hu, Wenxian, et al.
Publicado: (2021)

Hybrid System for Local Drug Delivery and Magnetic Hyperthermia Based on SPIONs Loaded with Doxorubicin and Epirubicin
por: Nieciecka, Dorota, et al.
Publicado: (2021)

MiR-320a as a Potential Novel Circulating Biomarker of Arrhythmogenic CardioMyopathy
por: Sommariva, Elena, et al.
Publicado: (2017)

Two hits are better than one: synergistic anticancer activity of α-helical peptides and doxorubicin/epirubicin
por: Zhao, Jing, et al.
Publicado: (2014)

Natriuretic peptide and cardiac troponin levels in doxorubicin-induced cardiotoxicity
por: Gülgün, Mustafa, et al.
Publicado: (2016)

Cardioncological Approach for Trastuzumab Therapy in Breast Cancer Patients With Cardiotoxicity: Impact on Adherence and Clinical Outcome
por: Fabiani, Iacopo, et al.
Publicado: (2020)

Comparison of safety and toxicity of liposomal doxorubicin vs. conventional anthracyclines: a meta-analysis
por: Rafiyath, Shamudheen M, et al.
Publicado: (2012)

Cardio-oncology: a new medical issue
por: Cardinale, D, et al.
Publicado: (2008)

Evaluation of Oxford Nanopore MinION RNA-Seq Performance for Human Primary Cells
por: Massaiu, Ilaria, et al.
Publicado: (2021)

Incidence, Management, Prevention and Outcome of Post-Operative Atrial Fibrillation in Thoracic Surgical Oncology
por: Fabiani, Iacopo, et al.
Publicado: (2019)

Histone Deacetylase Inhibition Enhances Self Renewal and Cardioprotection by Human Cord Blood-Derived CD34(+) Cells
por: Burba, Ilaria, et al.
Publicado: (2011)

Epirubicin is not Superior to Doxorubicin in the Treatment of Advanced Soft Tissue Sarcomas.The Experience of the EORTC Soft Tissue and Bone Sarcoma Group
por: Nielsen, Ole S., et al.
Publicado: (2000)

Gene Regulatory Network Analysis of Perivascular Adipose Tissue of Abdominal Aortic Aneurysm Identifies Master Regulators of Key Pathogenetic Pathways
por: Piacentini, Luca, et al.
Publicado: (2020)

Oxidative Stress and Cellular Response to Doxorubicin: A Common Factor in the Complex Milieu of Anthracycline Cardiotoxicity
por: Cappetta, Donato, et al.
Publicado: (2017)

Study on the infusion-site adverse events and vascular distribution of epirubicin in chemotherapy with epirubicin and fosaprepitant
por: Yamasaki, Miho, et al.
Publicado: (2019)

Epirubicin-induced Kounis syndrome
por: Liang, Hui-zhu, et al.
Publicado: (2021)

Cardiac Troponins are Among Targets of Doxorubicin-Induced Cardiotoxicity in hiPCS-CMs
por: Adamcova, Michaela, et al.
Publicado: (2019)

Effectiveness and safety of pegylated liposomal doxorubicin versus epirubicin as neoadjuvant or adjuvant chemotherapy for breast cancer: a real-world study
por: Zhang, Jin, et al.
Publicado: (2021)

Relationship between post-cardiac arrest myocardial oxidative stress and myocardial dysfunction in the rat
por: Hackenhaar, Fernanda Schäfer, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_dlpi3l8kj20sqsid98dlsfsjv4